文献速递脊柱关节炎

脊柱关节炎的合并症管理

Comorbidity management in spondyloarthritis.
PubMed 文献 · RMD Open · 2020-01-01

本文综述脊柱关节炎(SpA)常见合并症及其管理的最新证据。骨质疏松是最常见的合并症,主要由系统性炎症和活动不足引起;心血管疾病是SpA患者死亡率高于一般人群的主要原因。随机对照试验数据显示,无论是否接受免疫抑制治疗,感染发生率均较低,且未证实恶性肿瘤高发;合并纤维肌痛可导致治疗反应更差并增加抗TNF药物更换。

要点

  • 骨质疏松是SpA最常见的合并症,与系统性炎症和活动不足相关。
  • 心血管疾病是SpA患者死亡率高于一般人群的主要原因。
  • 合并纤维肌痛可致治疗反应更差并增加抗TNF药物更换。

核心结论

  • SpA合并症常见,与生活质量差、死亡率高和医疗费用增加相关。
  • 近期已制定多项合并症筛查与管理推荐,以改善患者结局。
  • 骨质疏松是SpA最 prevalent 的合并症,心血管疾病解释死亡率增加。

研究设计与样本

  • 本文为综述,更新SpA患者最常见合并症及管理的最新证据。

主要发现

  • 骨质疏松是SpA患者最 prevalent 的合并症,主要由系统性炎症和活动不足引起。
  • 心血管疾病解释SpA患者相对于一般人群的死亡率增加。
  • 随机对照试验数据显示,无论是否接受免疫抑制治疗,感染发生率均较低。
  • 未证实SpA患者恶性肿瘤高发。
  • 合并纤维肌痛与SpA共存可导致治疗反应更差并增加抗TNF药物更换。

临床怎么用

  • 临床应关注SpA患者骨质疏松、心血管疾病、纤维肌痛等常见合并症的筛查与管理。
  • 合并纤维肌痛可能提示抗TNF治疗反应不佳,需注意评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Comorbidities are defined as coexistent clinical disorders that appear as a consequence of persistent inflammatory activity and/or treatment. Comorbidities in spondyloarthritis (SpA) are frequent, contributing to a poorer quality of life, higher mortality and incremented healthcare costs. Several recommendations for the screening and management of these comorbidities have been developed in recent years with the aim of improving the different outcomes in these patients. Osteoporosis is the most prevalent comorbidity in patients with SpA, mainly caused by systemic inflammation and a lack of mobility, while cardiovascular diseases explain the increased mortality in patients with SpA with regard to the general population. Data from randomised controlled trials show a low incidence of infections in both patients with and without immunosuppressive treatment, and no evidence of a high incidence of malignant diseases has been demonstrated in these patients. Finally, concomitant fibromyalgia deserves attention, since its coexistence with SpA leads to a poorer treatment response and more switches of anti-TNF treatments. In this review, we show an update of the most common comorbidities in patients with SpA, and we discuss the latest evidence on the management of such comorbidities.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. López-Medina C, Molto A. Comorbidity management in spondyloarthritis. RMD Open. 2020. PMID: 32892168. doi:10.1136/rmdopen-2019-001135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。